b'2019NovemberOur story RecentNanoform wins the CPhI Excellence in Pharma Award for FormulationOur story started in 2008 milestones 2020when Prof. Jouko Yliruusi and Prof. Edward Hggstrm first combined their respective expertiseMay JuneNanoform awardedInitial Public Offering of in pharmaceutical technologyGMP certification Nanoform on Nasdaq First and physics. This extraordinaryNovember North Premier Growth MarketNanoform launchesDecembercollaboration produced a noveltechnology for biologicsNanoform makes US TV debut particle engineering technologyin Advancements with Ted Danson (CNBC) and light up with the ability to transform theTimes Square, New Yorkpharmaceutical industry.They discovered the Controlled Expansion of2021Supercritical Solutions (CESS) process in 2012 at the University of Helsinki and Nanoform was founded in 2015. Since then, Nanoform has expanded rapidly, transforming into a company Februarywith global ambition. Our cutting-edge nanoformingNanoform and HerantisMarchsign Biologics Proof Nanoform launchesservices are intended to help the globalof Concept Agreement next-generation STARMAP 2.0, the AI-based drug candidate pharmaceutical industry to double its annual newMarch selection tool for CESSmedicines output. We are proud to be a FinnishCESS benchmarking success story with an international outlook. study with JohnsonMarchMatthey Plc Nanoform and Nacuity Pharmaceuticals Sign Technology April Proof of Concept Agreement for Nanoform and ApreciaTwo Ophthalmic Drug Candidatescollaborate to advance 3D printed Nanomedicines MayNanoforms final clinical results May confirm value proposition to Nanoform and Celanesethe pharmaceutical industryExplore Ways to Enhance Drug Delivery AugustNanoform and Boehringer Ingelheim September execute master services agreement to Nanoform technologyassess the added value Nanoforms delivers successfulaward-winning CESS technology can results for Herantisdeliver to drug development projects.CDNF drug candidate SeptemberProof of Concept studies to be funded by the Bill & Melinda Gates Foundation to assess the added value Nanoforms award-winning CESS nanoparticle 4 engineering technology can deliver to5several of its drug development projects'